US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 17.330
  • +0.310+1.82%
Close Nov 15 16:00 ET
  • 17.330
  • 0.0000.00%
Post 16:02 ET
440.44MMarket Cap-375P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
248.57%13.69M
-45.99%-14.45M
-81.60%-15.92M
-61.74%-51.16M
-96.52%-23.29M
-311.69%-9.22M
19.36%-9.9M
26.12%-8.77M
47.62%-31.63M
62.34%-11.85M
Net income from continuing operations
-168.64%-24.18M
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
Operating gains losses
-86.05%-5.67M
161.63%3.91M
43.42%5.85M
756.57%138.07M
1,157.92%143.38M
-146.60%-3.05M
-236.45%-6.34M
121.86%4.08M
-999.06%-21.03M
-50.66%-13.55M
Depreciation and amortization
51.32%286K
11.36%196K
-11.17%183K
-34.50%843K
12.86%272K
-46.00%189K
-48.99%176K
-41.31%206K
2.80%1.29M
-39.90%241K
Deferred tax
----
----
----
---19M
----
----
----
----
--0
----
Other non cash items
4,300.28%15.75M
-438.50%-1.9M
4,790.91%39.81M
795.59%20.51M
3,120.58%18.78M
-33.33%358K
13.56%561K
20.41%814K
7.46%2.29M
16.83%583K
Change In working capital
76,008.82%25.81M
-1,068.25%-32.08M
-213.69%-6.37M
108.23%4.97M
44.48%-3.91M
-101.45%-34K
111.07%3.31M
121.75%5.6M
-25.28%-60.38M
81.41%-7.04M
-Change in receivables
9,019.52%29.7M
-1,488.72%-31.14M
315.89%4.48M
481.41%907K
26.65%-2.08M
-101.95%-333K
113.31%2.24M
-61.03%1.08M
105.80%156K
-9.38%-2.83M
-Change in prepaid assets
-146.75%-2.09M
43.23%1.2M
8,360.00%1.65M
-151.19%-1.27M
-144.50%-1.24M
-1,307.14%-845K
168.05%835K
-102.34%-20K
270.30%2.47M
394.90%2.78M
-Change in payables and accrued expense
-185.28%-1.81M
-294.04%-1.73M
-53.06%-7.06M
-95.71%73K
-0.24%1.68M
320.60%2.12M
-74.35%890K
-85.59%-4.61M
18.02%1.7M
109.72%1.68M
-Change in other working capital
--0
37.00%-412K
-159.37%-5.44M
108.12%5.26M
73.77%-2.27M
92.94%-976K
95.73%-654K
134.06%9.16M
-42.23%-64.71M
49.26%-8.66M
Cash from discontinued investing activities
Operating cash flow
248.57%13.69M
-45.99%-14.45M
-81.60%-15.92M
-61.74%-51.16M
-96.52%-23.29M
-311.69%-9.22M
19.36%-9.9M
26.12%-8.77M
47.62%-31.63M
62.34%-11.85M
Investing cash flow
Cash flow from continuing investing activities
-6.2M
-13,125.00%-1.59M
-102.14%-602K
330.70%34.61M
18.36%6.5M
0
87.88%-12K
194.65%28.12M
12.47%-15M
-43.54%5.49M
Net PPE purchase and sale
---6.2M
-13,125.00%-1.59M
-363.08%-602K
82.85%-206K
69.67%-64K
--0
87.88%-12K
71.43%-130K
-10.69%-1.2M
24.10%-211K
Net business purchase and sale
----
----
----
--6.56M
----
----
----
----
--0
----
Net investment purchase and sale
--0
--0
--0
304.72%28.25M
--0
--0
--0
182.54%28.25M
14.04%-13.8M
-43.00%5.7M
Cash from discontinued investing activities
Investing cash flow
---6.2M
-13,125.00%-1.59M
-102.14%-602K
330.70%34.61M
18.36%6.5M
--0
87.88%-12K
194.65%28.12M
12.47%-15M
-43.54%5.49M
Financing cash flow
Cash flow from continuing financing activities
602.21%124.49M
104.64%120K
28,779.87%43.03M
-133.52%-13.15M
14.08M
-4,150.49%-24.79M
-107.01%-2.59M
-91.38%149K
-25.87%39.22M
0
Net issuance payments of debt
--0
----
----
---27.46M
--0
---24.87M
----
----
--0
--0
Net common stock issuance
----
----
----
-115.83%-6.17M
---6.17M
----
----
----
-24.98%38.98M
--0
Net preferred stock issuance
--0
--0
--40M
--20.25M
--20.25M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
-31.71%56K
--120K
1,934.23%3.03M
-33.04%231K
--0
-58.38%82K
--0
0.68%149K
-63.26%345K
--0
Net other financing activities
----
----
----
----
----
----
----
----
---110K
--0
Cash from discontinued financing activities
Financing cash flow
602.21%124.49M
104.64%120K
28,779.87%43.03M
-133.52%-13.15M
--14.08M
-4,150.49%-24.79M
-107.01%-2.59M
-91.38%149K
-25.87%39.22M
--0
Net cash flow
Beginning cash position
-22.70%88.9M
-17.82%104.8M
-27.54%78.29M
-6.41%108.04M
-29.24%80.98M
-17.52%115M
11.07%127.53M
-6.41%108.04M
-17.58%115.44M
-1.36%114.44M
Current changes in cash
488.15%131.99M
-27.38%-15.91M
35.90%26.51M
-300.34%-29.7M
57.42%-2.71M
-36.17%-34M
-150.98%-12.49M
3,400.85%19.51M
69.88%-7.42M
-992.78%-6.36M
Effect of exchange rate changes
25.00%-15K
150.00%14K
76.19%-5K
-365.00%-53K
135.56%16K
4.76%-20K
-124.35%-28K
27.59%-21K
766.67%20K
-650.00%-45K
End cash Position
172.74%220.87M
-22.70%88.9M
-17.82%104.8M
-27.54%78.29M
-27.54%78.29M
-29.24%80.98M
-17.52%115M
11.07%127.53M
-6.41%108.04M
-6.41%108.04M
Free cash flow
181.30%7.49M
-61.84%-16.03M
-85.71%-16.52M
-56.45%-51.37M
-93.62%-23.35M
-335.26%-9.22M
19.91%-9.91M
27.79%-8.9M
46.59%-32.83M
62.00%-12.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 248.57%13.69M-45.99%-14.45M-81.60%-15.92M-61.74%-51.16M-96.52%-23.29M-311.69%-9.22M19.36%-9.9M26.12%-8.77M47.62%-31.63M62.34%-11.85M
Net income from continuing operations -168.64%-24.18M221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M
Operating gains losses -86.05%-5.67M161.63%3.91M43.42%5.85M756.57%138.07M1,157.92%143.38M-146.60%-3.05M-236.45%-6.34M121.86%4.08M-999.06%-21.03M-50.66%-13.55M
Depreciation and amortization 51.32%286K11.36%196K-11.17%183K-34.50%843K12.86%272K-46.00%189K-48.99%176K-41.31%206K2.80%1.29M-39.90%241K
Deferred tax ---------------19M------------------0----
Other non cash items 4,300.28%15.75M-438.50%-1.9M4,790.91%39.81M795.59%20.51M3,120.58%18.78M-33.33%358K13.56%561K20.41%814K7.46%2.29M16.83%583K
Change In working capital 76,008.82%25.81M-1,068.25%-32.08M-213.69%-6.37M108.23%4.97M44.48%-3.91M-101.45%-34K111.07%3.31M121.75%5.6M-25.28%-60.38M81.41%-7.04M
-Change in receivables 9,019.52%29.7M-1,488.72%-31.14M315.89%4.48M481.41%907K26.65%-2.08M-101.95%-333K113.31%2.24M-61.03%1.08M105.80%156K-9.38%-2.83M
-Change in prepaid assets -146.75%-2.09M43.23%1.2M8,360.00%1.65M-151.19%-1.27M-144.50%-1.24M-1,307.14%-845K168.05%835K-102.34%-20K270.30%2.47M394.90%2.78M
-Change in payables and accrued expense -185.28%-1.81M-294.04%-1.73M-53.06%-7.06M-95.71%73K-0.24%1.68M320.60%2.12M-74.35%890K-85.59%-4.61M18.02%1.7M109.72%1.68M
-Change in other working capital --037.00%-412K-159.37%-5.44M108.12%5.26M73.77%-2.27M92.94%-976K95.73%-654K134.06%9.16M-42.23%-64.71M49.26%-8.66M
Cash from discontinued investing activities
Operating cash flow 248.57%13.69M-45.99%-14.45M-81.60%-15.92M-61.74%-51.16M-96.52%-23.29M-311.69%-9.22M19.36%-9.9M26.12%-8.77M47.62%-31.63M62.34%-11.85M
Investing cash flow
Cash flow from continuing investing activities -6.2M-13,125.00%-1.59M-102.14%-602K330.70%34.61M18.36%6.5M087.88%-12K194.65%28.12M12.47%-15M-43.54%5.49M
Net PPE purchase and sale ---6.2M-13,125.00%-1.59M-363.08%-602K82.85%-206K69.67%-64K--087.88%-12K71.43%-130K-10.69%-1.2M24.10%-211K
Net business purchase and sale --------------6.56M------------------0----
Net investment purchase and sale --0--0--0304.72%28.25M--0--0--0182.54%28.25M14.04%-13.8M-43.00%5.7M
Cash from discontinued investing activities
Investing cash flow ---6.2M-13,125.00%-1.59M-102.14%-602K330.70%34.61M18.36%6.5M--087.88%-12K194.65%28.12M12.47%-15M-43.54%5.49M
Financing cash flow
Cash flow from continuing financing activities 602.21%124.49M104.64%120K28,779.87%43.03M-133.52%-13.15M14.08M-4,150.49%-24.79M-107.01%-2.59M-91.38%149K-25.87%39.22M0
Net issuance payments of debt --0-----------27.46M--0---24.87M----------0--0
Net common stock issuance -------------115.83%-6.17M---6.17M-------------24.98%38.98M--0
Net preferred stock issuance --0--0--40M--20.25M--20.25M--0--0--0--0----
Proceeds from stock option exercised by employees -31.71%56K--120K1,934.23%3.03M-33.04%231K--0-58.38%82K--00.68%149K-63.26%345K--0
Net other financing activities -----------------------------------110K--0
Cash from discontinued financing activities
Financing cash flow 602.21%124.49M104.64%120K28,779.87%43.03M-133.52%-13.15M--14.08M-4,150.49%-24.79M-107.01%-2.59M-91.38%149K-25.87%39.22M--0
Net cash flow
Beginning cash position -22.70%88.9M-17.82%104.8M-27.54%78.29M-6.41%108.04M-29.24%80.98M-17.52%115M11.07%127.53M-6.41%108.04M-17.58%115.44M-1.36%114.44M
Current changes in cash 488.15%131.99M-27.38%-15.91M35.90%26.51M-300.34%-29.7M57.42%-2.71M-36.17%-34M-150.98%-12.49M3,400.85%19.51M69.88%-7.42M-992.78%-6.36M
Effect of exchange rate changes 25.00%-15K150.00%14K76.19%-5K-365.00%-53K135.56%16K4.76%-20K-124.35%-28K27.59%-21K766.67%20K-650.00%-45K
End cash Position 172.74%220.87M-22.70%88.9M-17.82%104.8M-27.54%78.29M-27.54%78.29M-29.24%80.98M-17.52%115M11.07%127.53M-6.41%108.04M-6.41%108.04M
Free cash flow 181.30%7.49M-61.84%-16.03M-85.71%-16.52M-56.45%-51.37M-93.62%-23.35M-335.26%-9.22M19.91%-9.91M27.79%-8.9M46.59%-32.83M62.00%-12.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data